Skip to content

Brain Lesions Following Endovascular and Surgical Treatment of Unruptured Intracranial Aneurysms

Brain Lesions Following Endovascular and Surgical Treatment of Unruptured Intracranial Aneurysms: Incidence and Influence on Clinical Outcome in a Prospective Study.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01490463
Acronym
LESUIA
Enrollment
Unknown
Registered
2011-12-13
Start date
2011-08-31
Completion date
2013-01-31
Last updated
2013-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unruptured Intracranial Aneurysms

Keywords

Treatment of

Brief summary

The purpose of this study is to determine the incidence and impact of brain lesions in MRI after coiling and clipping of unruptured intracranial aneurysms on clinical and neurological outcome of patients.

Detailed description

Silent ischemic lesions after treatment of unruptured intracranial aneurysm (UIA) might alter patients' clinical and neurological outcome. Furthermore silent brain lesions are not well documented after endovascular and surgical treatment of unruptured intracranial aneurysms. Therefore, the investigators investigate the incidence and influence of treatment-related ischemic lesions in magnetic resonance / diffusion-weighted-imaging after endovascular and surgical treatment of UIA.

Interventions

None listed

Sponsors

Department of Neurosurgery, Goethe-University Frankfurt am Main
CollaboratorUNKNOWN
Institute of Neuroradiology, Goethe-University Frankfurt am Main
CollaboratorUNKNOWN
Johann Wolfgang Goethe University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* diagnosis and treatment of unruptured intracranial aneurysm * age ≥ 18 yrs * written informed consent by patients prior to study participation * willingness to participate in follow-up

Exclusion criteria

* ruptured intracranial aneurysm * contraindication for MRI * Participation in an intervention-/AMG-study

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026